As Testosterone Treatment Lawsuits Mount, Bernstein Liebhard LLP Notes New Study That Raises Questio

The Firm is evaluating testosterone lawsuits on behalf of men who suffered heart attacks, strokes and other cardiovascular problems, allegedly due to prescription testosterone therapies. New York, New York (PRWEB) April 07, 2014 As testosterone treatment lawsuits (http://www.testosteronelawsuitcenter.com/) involving AndroGel, Testim and other prescription low testosterone therapies continue to mount in U.S. Courts, Bernstein Liebhard LLP notes the publication of a new study that raises concern about the impact of direct-to-consumer pharmaceutical advertising. The research, which appears t
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations